Developmental origins of colon smooth muscle dysfunction in IBS-like rats

Qingjie Li1, John H Winston, Sushil K Sarna

  • 1Div. of Gastroenterology, The Univ. of Texas Medical Branch at Galveston, 8.102 Medical Research Bldg., Galveston, TX 77555-1083. sksarna@utmb.edu.

Insights

Neonatal colon inflammation in rats increases VIP, altering gene expression in smooth muscle. This epigenetic change may explain adult smooth muscle dysfunction and irritable bowel syndrome (IBS) symptoms.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Epigenetics

Background:

  • Irritable bowel syndrome (IBS) is linked to early-life stress.
  • Colonic smooth muscle dysfunction contributes to IBS.
  • Cellular mechanisms underlying this dysfunction require elucidation.

Purpose of the Study:

  • To investigate the cellular and epigenetic mechanisms of colonic smooth muscle dysfunction following neonatal inflammation in rats.
  • To determine the role of vasoactive intestinal peptide (VIP) and epigenetic modifications in regulating Cav1.2b channel expression.

Main Methods:

  • Neonatal rats were induced with colonic inflammation using 2,4,6-trinitrobenzene sulfonic acid.
  • Colonic smooth muscle function and gene expression (Cav1.2b, VIP mRNA) were assessed in adulthood.
  • Epigenetic modifications (histone acetylation, HDAC3 interaction) at the Cav1.2b promoter were analyzed.

Main Results:

  • Neonatal inflammation led to increased Cav1.2b channel subunit and VIP mRNA in adult rat colonic smooth muscle.
  • Reduced histone deacetylase 3 (HDAC3) interaction with the Cav1.2b promoter increased histone H3 lysine 9 (H3K9) acetylation.
  • VIP treatment mimicked these epigenetic changes, suggesting a role in regulating gene transcription.

Conclusions:

  • Neonatal inflammation upregulates VIP, inducing epigenetic changes at the Cav1.2b promoter, leading to smooth muscle dysfunction.
  • Early-life inflammatory insults may contribute to adult-onset IBS, particularly diarrhea-predominant IBS.
  • This study reveals a novel epigenetic mechanism linking early-life inflammation to gut motility disorders.

Related Concept Videos

Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: